Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.
[Contributions of the First International Consensus on grade 1 Hypertension with low to moderate cardiovascular risk].
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.
Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A.
Curr Probl Cardiol. 2017 Jul;42(7):198-225. doi: 10.1016/j.cpcardiol.2017.03.001. Epub 2017 Mar 8.
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Sundström J, Lind L, Nowrouzi S, Hagström E, Held C, Lytsy P, Neal B, Marttala K, Östlund O.
JAMA. 2023 Apr 11;329(14):1160-1169. doi: 10.1001/jama.2023.3322.
Beta-blockers for hypertension.
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH.
Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5.
Exercise-based rehabilitation programmes for pulmonary hypertension.
Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE.
Cochrane Database Syst Rev. 2023 Mar 22;3(3):CD011285. doi: 10.1002/14651858.CD011285.pub3.
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension.
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, Zhu L, Hu F, Li X, Meng S, Yan R, Zhao S, Onwuka JU, Yang B, Sun D, Zhao Y.
J Am Heart Assoc. 2020 Oct 20;9(19):e016804. doi: 10.1161/JAHA.120.016804. Epub 2020 Sep 25.
Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.
Lee CJ, Hwang J, Kang CY, Kim HC, Ryu DR, Ihm SH, Kim YJ, Shin JH, Pyun WB, Kim C, Park S.
J Hypertens. 2021 Aug 1;39(8):1662-1669. doi: 10.1097/HJH.0000000000002820.
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF.
Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3.
Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis.
Richards EMF, Giorgione V, Stevens O, Thilaganathan B.
Am J Obstet Gynecol. 2023 Apr;228(4):395-408. doi: 10.1016/j.ajog.2022.09.046. Epub 2022 Oct 7.
Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses.
Reynolds AN, Akerman A, Kumar S, Diep Pham HT, Coffey S, Mann J.
BMC Med. 2022 Apr 22;20(1):139. doi: 10.1186/s12916-022-02328-x.
